Jennifer Rider
About Jennifer Rider
Jennifer Rider is the Head of Real-World Evidence Services, holding a ScD and an MPH, with expertise in public health, epidemiology, and real-world data solutions in oncology.
Jennifer Rider - Head of Real-World Evidence Services
Jennifer Rider holds the position of Head of Real-World Evidence Services. In this role, she directs efforts to utilize real-world data and evidence for enhancing healthcare outcomes. Her extensive experience in managing diverse data solutions and evidence-based approaches contributes significantly to the field of public health, particularly in oncology.
Jennifer Rider's Education and Expertise
Jennifer Rider has a Doctor of Science (ScD) and a Master of Public Health (MPH). These qualifications underpin her expertise in real-world evidence and public health. Her education provides a strong foundation for her work in epidemiology and healthcare data solutions, ensuring she can effectively leverage data to inform medical decisions and policy.
Jennifer Rider's Background in Public Health and Epidemiology
Jennifer Rider has a robust background in public health and epidemiology. Her work has consistently focused on understanding disease patterns and outcomes using real-world data. She engages in research and projects that aim to improve public health frameworks and patient outcomes, especially in oncology.
Publications on Real-World Outcomes in Oncology by Jennifer Rider
Jennifer Rider has published research focusing on real-world outcomes in oncology. Her studies provide valuable insights into how real-world data can be utilized to assess and improve cancer treatments and patient care. These publications contribute to the growing body of evidence that supports the role of real-world evidence in advancing oncology.
Jennifer Rider in ConcertAI Podcast
Jennifer Rider was featured in a ConcertAI podcast where she discussed the application of real-world data in oncology. Through this platform, she shared her insights on how real-world evidence can shape the future of cancer treatment and care, highlighting her expertise and commitment to advancements in healthcare data solutions.